On July 30, Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. and Shenzhen Peptide Sheng Biotechnology Co., Ltd. signed an agreement and reached a strategic cooperation relationship. The two parties will integrate resources

The project "Construction of innovative peptide library and research and development of innovative peptide drugs" applied by Shenzhen Peptide Biotechnology Co., Ltd. (hereinafter referred to as "Peptide Bio"), an enterprise in the Shenzhen Bay Laboratory Pingshan Center Incubator, has been approved and supported by the Shenzhen Science and Technolo

The biopharmaceutical industry is an important strategic industry of the "14+7" industrial cluster in Nanshan District. In recent years, with the development and maturity of peptide synthesis technology, peptide drugs have become one of the hot spots in drug research and development.

On July 11, Shenzhen Lihe Biotechnology Co., Ltd. and Shenzhen Peptide Sheng Biotechnology Co., Ltd. signed an agreement and reached a strategic cooperation relationship. The two parties will integrate resources to jointly promote the construction of the world's first entity peptide library application development that combines peptide structural d